{"_links": {"parentPackage": {"href": "/mdr/ct/packages/protocolct-2018-06-29", "title": "PROTOCOL Controlled Terminology Package 34 Effective 2018-06-29", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/protocolct-2018-03-30/codelists/C142191", "title": "CDISC Protocol Entities Clinical Study Attribute Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/protocolct/codelists/C142191", "title": "Version-agnostic anchor resource for codelist C142191", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/protocolct-2018-06-29/codelists/C142191", "title": "CDISC Protocol Entities Clinical Study Attribute Terminology", "type": "Code List"}}, "conceptId": "C142191", "definition": "A terminology value set relevant to the attributes of the clinical study entity.", "name": "Clinical Study Attribute Terminology", "preferredTerm": "CDISC Protocol Entities Clinical Study Attribute Terminology", "submissionValue": "Clinical Study Attribute Terminology", "synonyms": ["Clinical Study Attribute Terminology"], "terms": [{"conceptId": "C70794", "definition": "The individual, organization, group or other legal person taking responsibility for securing the arrangements to initiate and/or manage a study (including arrangements to ensure that the study design meets appropriate standards and to ensure appropriate conduct and reporting). In commercial trials, the primary sponsor is normally the main applicant for regulatory authorization to begin the study. It may or may not be the main funder. (NCI)", "preferredTerm": "Primary Clinical Study Sponsor", "submissionValue": "Primary Clinical Study Sponsor"}, {"conceptId": "C70795", "definition": "Additional individuals, organizations or other legal persons, if any, that have agreed with the primary sponsor to take on responsibilities of sponsorship. A secondary sponsor may have agreed to take on all the responsibilities of sponsorship jointly with the primary sponsor; or to form a group with the primary sponsor in which the responsibilities of sponsorship are allocated among the members of the group; or to act as the sponsor's legal representative in relation to some or all of the study sites; or to take responsibility for the accuracy of study registration information submitted.", "preferredTerm": "Secondary Clinical Study Sponsor", "submissionValue": "Secondary Clinical Study Sponsor"}, {"conceptId": "C71473", "definition": "An action, undertaking, or event, which is anticipated to be performed or observed, or was performed or observed, according to the study protocol during the execution of the study.", "preferredTerm": "Study Activity", "submissionValue": "Study Activity"}, {"conceptId": "C94122", "definition": "A statement describing the overall rationale of the study. This field describes the contribution of this study to product development, i.e., what knowledge is being contributed from the conduct of this study.", "preferredTerm": "Study Protocol Version Purpose Statement", "submissionValue": "Study Rationale", "synonyms": ["Study Purpose"]}, {"conceptId": "C93682", "definition": "A diagram that outlines the decision points (e.g. randomization, response evaluation) that define the different paths a subject could take through the study. This is typically a block diagram and may include epochs, timing of randomization, treatment arms, and duration of treatments.", "preferredTerm": "Study Schematic", "submissionValue": "Study Schematic Diagram", "synonyms": ["Study Schema"]}, {"conceptId": "C142175", "definition": "Describes the role the study plays in determining the interventions a subject receives.", "preferredTerm": "Study Type", "submissionValue": "Study Type", "synonyms": ["Study Type"]}]}